ATS Breathe Easy

How can peers help those in their field entering mid-career? Through the sharing of their successes and struggles. This was the solution Joshua Lee Denson, MD, MS, Tulane University, and colleagues came up with when asked for event ideas for the ATS International Conference. The ATS Storytelling Series has been a huge success, giving mid-career professionals a space to highlight wins, discuss issues, and connect with a community of professionals looking to advance and expand. Dr. Denson and host Amy Attaway, MD, Cleveland Clinic, talk about how this series was developed, how it has helped others in the past, and what to look forward to at ATS 2026. 
Be sure to register for ATS 2026: https://registration.experientevent.com/ShowATS261/Flow/ATT?atslogin=1&marketingcode=YOUTUBE

Immigrants make up a significant portion of the medical and scientific community at all levels, from students all the way to senior faculty. But the Trump administration’s new policies will make it hard for institutions to bring in new international talent and possibly retain the key contributors. 
Host Patti Tripathi talks with medical historian Eram Alam, PhD, Harvard University, and ATS Past-President Lynn Schnapp, MD, ATSF, University of Wisconsin, about how the fields of respiratory medicine and research are losing the best and the brightest, and what that means for public health. 
Learn more about the Hart-Celler Act: https://dissentmagazine.org/article/how-the-hart-celler-act-changed-america/

This is the second episode of our discussions on the experiences and challenges of transitioning into being a mid-career professional. 
For many, mid-career brings a wave of financial and personal pressure, leaving them working out how to handle new milestones and systems while managing their careers. Last Zebra Podcast creator Ugo Ezema, MD, of Tulane University hosts this episode. He speaks with fellow Tulane University colleague Joshua Lee Denson, MD, MS, and Kristina Montemayor, MD, MHS, Johns Hopkins University, about financial education, negotiation skills, retirement planning, leadership boundaries, and more.
Be sure to register for ATS 2026 for some of the great mid-career programs, including the ATS Storytelling series, the Mid-Career Roadmap and Toolkit, Scientific Symposium: Breathing New Life Into Your Career.

Are you looking for ways to grow your career and keep expanding your education as you transition out of your early-career days? Last Zebra Podcast creator Ugo Ezema, MD, of Tulane University, joins as this week’s host. He speaks with fellow Tulane University colleague Joshua Lee Denson, MD, MS, and Kristina Montemayor, MD, MHS, Johns Hopkins University, about opportunities for mid-career growth, including at ATS 2026, as well as challenges unique to those at this stage of their professional life.
Register for ATS 2026 and get insights on resources for mid-career professionals.

Biologics have changed how patients with asthma are able to handle their symptoms and prevent them from getting worse. Host Amy Attaway, MD, Cleveland Clinic, talks with Monica Kraft, MD, Icahn School of Medicine at Mount Sinai, and De De Gardner, DrPh, Allergy and Asthma Network and member of PAR about depemokimab, the newest biologic for those with severe asthma. Learn how this novel treatment is used once every six months to improve patient outcomes, as well as the research behind this biologic and the future of asthma treatment.
Read Dr. Kraft's paper on depemokimab: https://journal.chestnet.org/article/S0012-3692(25)00855-4/pdf 
Editor's note: During this episode, Dr. Kraft mistakenly said that depemokimab was approved for treating nasal polyps. Please note that depemokimab is not approved for treating this condition.